Literature DB >> 18641999

Adrenal phaeochromocytoma: correlation of MRI appearances with histology and function.

Audrey E T Jacques1, Anju Sahdev, Madrika Sandrasagara, Rick Goldstein, Daniel Berney, Andrea G Rockall, Shern Chew, Rodney H Reznek.   

Abstract

The purpose of this study was to describe the range of appearances of adrenal phaeochromocytomas on T2-weighted MRI, correlate appearances with histopathology, and quantify the incidence of the previously described hyperintense appearance. The appearance and MR characteristics of 44 phaeochromocytomas were reviewed retrospectively. T2-weighted appearances were grouped: (1) 'classical', homogeneous, high signal intensity, isointense to CSF; (2) homogeneous, isointense or minimally hyperintense to spleen, hypointense to CSF; (3) heterogeneous, marbled appearance; (4) heterogeneous, multiple high signal intensity pockets. All 44 adrenal phaeochromocytomas were well circumscribed, 1.2-15 cm in maximum diameter, with no visual or quantitative signal loss on chemical shift imaging. On T2-weighted MRI 5/44 (11%) had group 1 appearance; 15/44 (34%) group 2, 7/44 (16%) group 3; and 17/44 (39%) group 4. Homogeneous group 1 and 2 lesions were smaller (mean 4.5 cm) than heterogeneous group 3 and 4 lesions (mean 6.3 cm). Increasing MRI heterogeneity correlated pathologically with increasing amounts of haemorrhage, necrosis and fibrosis. No MRI features were predictive of malignancy. Non-functioning phaeochromocytomas were larger than functioning lesions. No size difference was seen between syndrome and sporadic lesions. In this large series we report a wide range of appearances of adrenal phaeochromocytomas on T2-weighted MRI. The previously described classical hyperintense phaeochromocytoma is relatively uncommon.

Entities:  

Mesh:

Year:  2008        PMID: 18641999     DOI: 10.1007/s00330-008-1073-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

Review 1.  MR imaging of the adrenal glands.

Authors:  Hero K Hussain; Melvyn Korobkin
Journal:  Magn Reson Imaging Clin N Am       Date:  2004-08       Impact factor: 2.266

2.  Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging.

Authors:  E K Outwater; E S Siegelman; P D Radecki; C W Piccoli; D G Mitchell
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

3.  MR characterization of adrenal masses: field strength and pulse sequence considerations.

Authors:  R Kier; S McCarthy
Journal:  Radiology       Date:  1989-06       Impact factor: 11.105

4.  MR evaluation of adrenal masses at 1.5 T.

Authors:  M E Baker; R Blinder; C Spritzer; G S Leight; R J Herfkens; N R Dunnick
Journal:  AJR Am J Roentgenol       Date:  1989-08       Impact factor: 3.959

5.  MR imaging of pheochromocytomas.

Authors:  I J Fink; J W Reinig; A J Dwyer; J L Doppman; W M Linehan; H R Keiser
Journal:  J Comput Assist Tomogr       Date:  1985 May-Jun       Impact factor: 1.826

6.  MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times.

Authors:  J C Varghese; P F Hahn; N Papanicolaou; W W Mayo-Smith; J A Gaa; M J Lee
Journal:  Clin Radiol       Date:  1997-08       Impact factor: 2.350

7.  Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.

Authors:  L E Quint; G M Glazer; I R Francis; B Shapiro; T L Chenevert
Journal:  Radiology       Date:  1987-10       Impact factor: 11.105

8.  Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging.

Authors:  Y Tsushima; H Ishizaka; M Matsumoto
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

9.  Adrenal masses differentiated by MR.

Authors:  J W Reinig; J L Doppman; A J Dwyer; A R Johnson; R H Knop
Journal:  Radiology       Date:  1986-01       Impact factor: 11.105

10.  MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.

Authors:  J H Bilbey; R F McLoughlin; P S Kurkjian; G E Wilkins; N H Chan; N Schmidt; J Singer
Journal:  AJR Am J Roentgenol       Date:  1995-03       Impact factor: 3.959

View more
  24 in total

1.  Images of pheochromocytoma in adrenal glands.

Authors:  Shaunagh McDermott; Colin J McCarthy; Michael A Blake
Journal:  Gland Surg       Date:  2015-08

Review 2.  The incremental benefit of functional imaging in pheochromocytoma/paraganglioma: a systematic review.

Authors:  Juan P Brito; Noor Asi; Michael R Gionfriddo; Catalina Norman; Aaron L Leppin; Claudia Zeballos-Palacios; Chaitanya Undavalli; Zhen Wang; Juan P Domecq; Gabriela Prustsky; Tarig A Elraiyah; Larry J Prokop; Victor M Montori; Mohammad Hassan Murad
Journal:  Endocrine       Date:  2015-02-06       Impact factor: 3.633

3.  Re: Adrenal pheochromocytoma: correlation of MRI appearances with histology and function.

Authors:  Byung Kwan Park
Journal:  Eur Radiol       Date:  2009-04-15       Impact factor: 5.315

Review 4.  Management of Adrenal Masses.

Authors:  Hattangadi Sanjay Bhat; Balagopal Nair Tiyadath
Journal:  Indian J Surg Oncol       Date:  2016-12-17

Review 5.  Pheochromocytomas and paragangliomas: assessment of malignant potential.

Authors:  Tim I M Korevaar; Ashley B Grossman
Journal:  Endocrine       Date:  2011-10-25       Impact factor: 3.633

6.  Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas.

Authors:  Aradhana M Venkatesan; Hari Trivedi; Karen T Adams; Electron Kebebew; Karel Pacak; Marybeth S Hughes
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

Review 7.  Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.

Authors:  Ioannis Ilias; Chaitanya Divgi; Karel Pacak
Journal:  Semin Nucl Med       Date:  2011-09       Impact factor: 4.446

8.  Clinical experience with pheochromocytoma in a single centre over 16 years.

Authors:  Dario Cotesta; Luigi Petramala; Valentina Serra; Mario Pergolini; Eleonora Crescenzi; Laura Zinnamosca; Giorgio De Toma; Antonio Ciardi; Iacopo Carbone; Rita Massa; Sebastiano Filetti; Claudio Letizia
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

Review 9.  Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome.

Authors:  Karel Pacak; Graeme Eisenhofer; Ioannis Ilias
Journal:  Hormones (Athens)       Date:  2009 Apr-Jun       Impact factor: 2.885

Review 10.  New imaging approaches to phaeochromocytomas and paragangliomas.

Authors:  Bas Havekes; Kathryn King; Edwin W Lai; Johannes A Romijn; Eleonora P M Corssmit; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-08       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.